Linked Life Data

7231281

Source:http://linkedlifedata.com/resource/pubmed/id/7231281

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1981-7-9
pubmed:abstractText
Carcinoembryonic antigen (CEA) has been monitored at intervals of approximately three months in patients who had undergone potentially curative surgery for breast cancer, head and neck cancer, lung cancer, and colorectal cancer, but who were considered to be at high risk of recurrence. Monitoring of CEA in patients' serum was of no value for the early detection of tumour recurrence in either breast or head and neck cancer patients. It was of value for the early detection of lung cancer recurrence, but these patients were always beyond the scope of cure. In colorectal cancer patients, two-thirds of recurrences were heralded by a rising CEA, but only one of 15 patients had disease confined to local tissues which could be totally excised, although a further three patients had liver metastases which were apparently localized to one lobe of the liver. For colorectal cancer patients, serial CEA estimations are an effective method for the early diagnosis of recurrence, although this seldom translates into improved patient benefit.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0025-729X
pubmed:author
pubmed:issnType
Print
pubmed:day
21
pubmed:volume
1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
177-8
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1981
pubmed:articleTitle
Value of serial carcinoembryonic antigen determinations for early detection of recurrent cancer.
pubmed:publicationType
Journal Article